How much is Morbid Opportunist worth right now?

Morbid Opportunist from Innistrad: Double Feature is trading around $1.01 on the secondary market. TCGIndex refreshes this price every day.

Is Morbid Opportunist going up or down?

Morbid Opportunist is up +3.7% over 30 days, up +0.9% over 7 days. The full price history is on this page.

Is Morbid Opportunist a good investment?

TCGIndex doesn't give financial advice, but here's the data worth knowing: it sits around $1.01, up +3.7% over the last 30 days, with low volatility. Prices can move fast, so look at the trend and your own timeframe before you buy.

Morbid Opportunist

Innistrad: Double FeatureUncommon#113

Investment snapshot●Neutral50%

$10.24

Trend

Neutral

Momentum

Flat

Volatility

Low

30-day

+3.7%

Why this card is worth watching

Trading near its 30-day high

View listings on TCGplayer

eBay sold prices

Price History34 days

$10

7d Changei

+0.91%

30d Changei

+3.74%

Volatilityi

low

Trendi

— neutral

30d Rangei

$9.48$10.24

Variants (6)

Condition	Printing	Price	7d Avg	30d Avg	Trend
Near Mint	Foil	$10.24	$9.93	$9.80	▲	Live
Moderately Played	Normal	$1.51	$1.22	$1.21	—	Live
Near Mint	Normal	$1.01	$1.04	$1.05	—	Live
Lightly Played	Normal	$1.31	$1.26	$1.22	▲	Live
Lightly Played	Foil	$8.39	$8.60	$8.54	—	Live
Moderately Played	Foil	$1.08	$1.08	$1.08	—	Live

Morbid Opportunist FAQ

How much is Morbid Opportunist worth right now?: Morbid Opportunist from Innistrad: Double Feature is trading around $1.01 on the secondary market. TCGIndex refreshes this price every day.
Is Morbid Opportunist going up or down?: Morbid Opportunist is up +3.7% over 30 days, up +0.9% over 7 days. The full price history is on this page.
Is Morbid Opportunist a good investment?: TCGIndex doesn't give financial advice, but here's the data worth knowing: it sits around $1.01, up +3.7% over the last 30 days, with low volatility. Prices can move fast, so look at the trend and your own timeframe before you buy.

Morbid Opportunist

Morbid Opportunist FAQ

More cards from Innistrad: Double Feature